DRIO DarioHealth Corporation: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

DarioHealth Corp. (DRIO) possesses significant pricing power due to the integration of smart glucometers with an AI coach for hypertension management. The projected 12-month EPS trajectory reflects market expectations, with the indicator settling at 34.50. The ecosystem of sensors and applications ensures stable subscription revenue. An impeccable image and corporate client loyalty confirm the company's leadership in digital medicine.

DRIO: Dinamika bathi saben saham sing diarepake ing taun ngarep DarioHealth Corp 04.07.2022 - 15.11.2026

Rincian analitis lan laporan data perusahaan DarioHealth Corp (DRIO)

- rega saham lan konsensus proyeksi valuasi:

Rega saham mydario.com|DRIO - Target median analis

- data kapitalisasi saham perusahaan:

Nilai pasar DarioHealth|DRIO - Total Nilai Perusahaan

- rincian nilai buku perusahaan:

Nilai Buku saben Saham DarioHealth|DRIO - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku mydario.com|DRIO - Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

- informasi bathi lan kelipatan valuasi:

DRIO - Bathi pungkasan|Proyeksi bathi mangsa ngarep DarioHealth Corp.|DRIO - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep DarioHealth Inc|DRIO - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan DarioHealth Corporation|DRIO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan DarioHealth|DRIO - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan mydario.com|DRIO - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep DarioHealth Corp.

- indikator dodolan lan pendapatan:

DRIO - Volume dodolan perusahaan|Prakiraan pendapatan perusahaan DarioHealth Corp.|DRIO - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S DarioHealth Inc|DRIO - Wutah pendapatan taunan sajrone rolas wulan kepungkur

Ringkesan analisis perusahaan:DarioHealth Corporation

DarioHealth Corp. (DRIO) aims for dominance in the telemedicine segment through the expansion of b2b2c subscriptions for US insurers. Analyzing the projected EPS growth for the coming year, an investor sees a consensus earnings per share forecast that reflects market expectations for the IT platform's scalability. While inflated forecasts promise high returns, they create the risk of a sharp capital correction if the business fails to meet its target performance metrics.

Pesaing langsung